100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary Psychology A-level Paper 3 Schizophrenia A* notes $13.62   Add to cart

Summary

Summary Psychology A-level Paper 3 Schizophrenia A* notes

 14 views  0 purchase
  • Course
  • Institution

You can set yourself up for success with notes that have been refined over two years to be as clear and effective as possible. I recently completed my Psychology A-levels with a predicted 3A*s, including a high score of 94/96 on Psychology Paper 3 in my mocks, using these notes. What these notes...

[Show more]

Preview 2 out of 5  pages

  • June 20, 2024
  • 5
  • 2023/2024
  • Summary
avatar-seller
Classification and Diagnosis
Reliability and Validity of schizophrenia
Biological explanations for schizophrenia
Biological treatments for schizophrenia
Psychological explanations for schizophrenia
Psychological treatments for schizophrenia
The interactionist approach to schizophrenia
Managing Schizophrenia - Token Economies


Biological Explanations for Schizophrenia
Genetic similarities
Gotteman et al large scale family study →
Aunt 2%, sibling 9%, identical twin 48%
Share environment and genes - correlation

Candidate genes - polygenic inheritance coding for dopamine
Ripke et al - SCZ genetic makeup vs control - separate variations found
Aetiologically heterogeneous

OG hypothesis → hypERdopaminergia - high dopamine in subcortical areas (positive symptoms)
REVIVED → hypOdopaminergia - low dopamine in prefrontal cortex (negative symptoms)
Cortical hypOdopaminergia leads to supcortical hypERdopaminergia

Support → Tienari et al - adoptees in Finland w/ biological SCZ mother 6.9% chance
Hilker et al → concordance rates 33% MZ and 7% DZ - regardless of environment, genes significant

Limitation → environment significant. Morgan et al → birth complications and smoking THC cannabis in teen
years. Psychological risk e.g childhood trauma leads to vulnerability in mental health. Morkved → 67% SCZ at
least 1 childhood trauma vs 38% matched group with no psychotic issues. Genetics aren’t complete.

Support → Amphetamines increase dopamine worsening SCZ symptoms (Curran et al). Antipsychotics reduce
dopamine, reducing symptoms. Noll et al → dont work ⅓ w/ positive symptoms

Limitation → McCutcheon → post mortem showed raised glutamate levels in SCZ patients
Moghaddan and Javitt → link between glutamate and SCZ symptoms
Antipsychotics should not just focus on dopamine



Classification and Diagnosis

A01 thoughts and emotions are impaired and contact is lost with external reality. affects 1% of the population,
most common psychotic disorder, mainly men. the clinician uses a diagnostic manual for criteria fitting. American
DSM-5 (5 positive symptoms - 6 months symptoms) and European ICD-11 (2 or more symptoms - symptoms 1
month). subtypes dropped as inconsistent

A01 Positive - delusions and hallucinations
Negative - Alogia and Avolition

A03 Osorio - DSM-5 reliability 180 people. Interrater reliability +.97 and test retest +.92. Removed old criteria -
positive symptoms bizarre (subjective)

A03 Ethnocentric - cultural differences
Pinto and Jones - British African Caribbean 9x likely SCZ than British people
Luhmann interviewed 60 adults - Ghana, India, USA
Africans and Infians - positive experiences

, Us - negative experiences
Different meanings, discriminated against by cultural biassed system

A03 Gender bias
Fisher and Buchanan - men more diagnosed, ration 1.4:1
Genetically vulnerable or clinician affecting diagnosis - men overdiagnosed
Cotton et al - women closer, more support
Loosing custody
Underdiagnosis - receiving less treatment

A03 Symptom overlap - SCZ and BPD (delusions and avolition)
Ellason and Ross - DID more symptoms of SCZ than SCZ patients


Reliability and Validity of Schizophrenia

A01 Reliability - Interater - two clinicians reach the same conclusions with the same manual/criteria. Kappa score
of 1 (perfect agreement) and 0 (no agreement). 0.7 above is good. DSM-5 - Whaley - 0.11 and Reiger 0.46.
Manuals not reliable causing misdiagnosis/ missed diagnosis. Not accessing the right treatment/services. Test
retest - same conclusions reached at two different times.

A03 Osorio excellent reliability in DSM-5 for 180 individuals. Inter rater +.97 and test retest +.92. Improved
reliability by removing criteria that positive symptoms have to be ‘bizarre’ enough - subjective, disagreed
meaning.

A01 Reliability - Culture Bias - Pinto and Jones - British African Caribbean 9x likely diagnosed vs white british.
Those in their own countries aren't. Ethnocentric - not reliable as different diagnosis for different cultures, not
consistent.

A03 Luhmann interviewed 20 adults from Ghana, India and US about voices. Positive - playful, offering advice,
negative - violent and hateful. Culture impacts symptom experience. Shouldn’t be used to classify in other
cultures.

A01 Validity - Gender bias - Fisher and Buchanan - men more diagnosed 1.4:1. Cotton et al - women function
better, likely to work with good family relationships.

A03 Loring and Powell - overdiagnosis of males and underdiagnosis females - not enough service/treatment.
Gender influences diagnosis, male psychiatrist overdiagnosed men. Women don't want to lose custody.

A01 Symptom overlap - SCZ and BPD (delusions) - may not be two conditions. Hard to distinguish and diagnose.
Variations of the same condition?

A03 Ellason and Ross - DID more SCZ symptoms than SCZ patients. SCZ criteria invalid, not distinct from other
disorders, misdiagnosis likely.

Biological treatments for schizophrenia

A01 Typical antipsychotics - reduce positive symptoms
Antagonists bind to D2 - blocking neurotransmission
Kapur et al - 60-70% D2 receptors blocked - tardive dyskinesia
Chlorpromazine - initially dopamine increase then reduced production
Sedative calming - not just SCZ condition

A01 Atypical antipsychotics - reduce negative symptoms
Antagonists bind to D2 - blocking neurotransmission TEMPORARILY
Rapidly dissociate allowing normal transmission
No tardive dyskinesia
Clozapine - acts on dopamine, serotonin and glutamate receptors

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller juliettenivelle4. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $13.62. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67866 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$13.62
  • (0)
  Add to cart